Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.

This study tests a new drug called efsubaglutide alfa in Chinese adolescents aged 12 to 17 with obesity. The goal is to check the drug's safety, how the body processes it, and its effects on weight. Participants receive either the drug or a placebo injection weekly for 12 weeks. …

This study tests a new drug called efsubaglutide alfa for weight loss in 200 adults who are overweight or obese. Participants receive weekly or biweekly injections for 22 weeks, and researchers measure how much weight they lose. The goal is to see if the drug is safe and effectiv…